Production (Stage)
Milestone Pharmaceuticals Inc.
MIST
$1.73
-$0.01-0.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.76M | -12.36M | -9.44M | -9.36M | -10.35M |
| Total Depreciation and Amortization | 27.00K | 567.00K | 25.00K | 26.00K | 28.00K |
| Total Amortization of Deferred Charges | 102.00K | 97.00K | 95.00K | 91.00K | 87.00K |
| Total Other Non-Cash Items | 2.10M | 1.64M | 2.09M | 2.07M | 2.20M |
| Change in Net Operating Assets | 4.58M | 3.22M | 208.00K | 1.13M | -899.00K |
| Cash from Operations | -13.95M | -6.84M | -7.02M | -6.05M | -8.93M |
| Capital Expenditure | -6.00K | -22.00K | -4.00K | -7.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.59M | 19.36M | 6.49M | 9.49M | -27.01M |
| Cash from Investing | 33.58M | 19.33M | 6.48M | 9.48M | -27.01M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 140.00K | 24.00K | 74.00K | -- | 27.66M |
| Repurchase of Common Stock | -- | -- | -- | -251.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -47.00K | 4.66M |
| Cash from Financing | 140.00K | 24.00K | 74.00K | -298.00K | 32.32M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.77M | 12.52M | -463.00K | 3.13M | -3.63M |